Sky Centy Invt Stock Price, News & Analysis
Company Description
Sky Centy Invt (SKYID) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $223.5K.
SKYID stock has declined 63.9% over the past year. Shares last traded at $0.2100.
On a trailing twelve-month basis, Sky Centy Invt reported revenue of $76K with net income of -$117K. The company operates at a net profit margin of -153.6%.
This page provides a comprehensive overview of SKYID stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Sky Centy Invt (SKYID) stock last traded at $0.2100. Over the past 12 months, the stock has lost 63.9%. At a market capitalization of $223.5K, SKYID is classified as a micro-cap stock with approximately 2.2M shares outstanding.
Latest News
SEC Filings
Sky Centy Invt has filed 1 recent SEC filing, including 1 Form 8-K. The most recent filing was submitted on February 25, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SKYID SEC filings →
Financial Highlights
Sky Centy Invt generated $76K in revenue over the trailing twelve months, retaining a 32.1% gross margin, operating income reached -$117K (-152.8% operating margin), and net income was -$117K, reflecting a -153.6% net profit margin. The company generated $46K in operating cash flow. With a current ratio of 0.01, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
SKYID Company Profile & Sector Positioning
Sky Centy Invt (SKYID) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector.